Repository logo

Infoscience

  • English
  • French
Log In
Logo EPFL, École polytechnique fédérale de Lausanne

Infoscience

  • English
  • French
Log In
  1. Home
  2. Academic and Research Output
  3. Conferences, Workshops, Symposiums, and Seminars
  4. P450-mediated electrochemical sensing of drugs in human plasma for personalized therapy
 
conference paper

P450-mediated electrochemical sensing of drugs in human plasma for personalized therapy

Cavallini, Andrea  
•
Carrara, Sandro  
•
De Micheli, Giovanni  
Show more
2010
Proceedings of the 6th Conference on Ph.D. Research in Microelectronics and Electronics (PRIME)
6th Conference on Ph.D. Research in Microelectronics and Electronics (PRIME)

Nowadays, the concept of personalized therapy gains momentum. Pharmacogenomics, which represents a first answer to these needs, has the drawback of neglecting some variations of therapy response due to non-genetic factors. The aim of this paper is to investigate the feasibility of a non-genetic approach to personalized therapy, via the point-of-care drug monitoring in biological fluids with electrochemical biosensors. The proposed biosensor is based on the use of P450 enzymes as probe molecules, thanks to their key role in human metabolism. Multiwalled carbon nanotubes are used to enhance biosensor sensitivity. Results show how the proposed system is capable to detect drug amounts within the corresponding pharmacological ranges in human serum.

  • Files
  • Details
  • Metrics
Loading...
Thumbnail Image
Name

P450 - PRIME 2010 - P450_Cavallini_.pdf

Access type

openaccess

Size

782.25 KB

Format

Adobe PDF

Checksum (MD5)

65bdb3962d01d080d6269ae7ae4177a3

Logo EPFL, École polytechnique fédérale de Lausanne
  • Contact
  • infoscience@epfl.ch

  • Follow us on Facebook
  • Follow us on Instagram
  • Follow us on LinkedIn
  • Follow us on X
  • Follow us on Youtube
AccessibilityLegal noticePrivacy policyCookie settingsEnd User AgreementGet helpFeedback

Infoscience is a service managed and provided by the Library and IT Services of EPFL. © EPFL, tous droits réservés